Relationship between depression and apolipoproteins A and B: a case-control study

Area of Science:

• Cardiology
• Psychiatry
• Metabolic Syndrome

Background:

• Limited evidence exists on the relationship between major depressive disorder (MDD) and coronary heart disease (CHD) metabolic risk factors.
• Specific focus on lipoproteins and apolipoproteins in MDD is lacking.

Purpose of the Study:

• To investigate the association between major depressive disorder and metabolic risk factors for coronary heart disease.
• To examine the relationship between depression severity and specific lipoprotein and apolipoprotein levels.

Main Methods:

• A case-control study involving 153 patients with MDD and 147 healthy controls.
• Data collection included demographic questionnaires, Hamilton Depression Rating Scale, anthropometric measurements, and blood sample analysis for lipids and apolipoproteins.
• Statistical analysis employed t-tests, chi-squared tests, Pearson correlation, and linear regression.

Main Results:

• Major depressive disorder negatively predicted apolipoprotein A and positively predicted apolipoprotein B.
• Apolipoprotein A levels were inversely associated with total cholesterol and positively with high-density lipoprotein.
• Low-density lipoprotein predicted apolipoprotein B, and depression severity correlated with altered apolipoprotein A and B levels.

Conclusions:

• A significant relationship exists between major depressive disorder and apolipoproteins A and B.
• Screening for these metabolic risk factors is crucial in depressed patients.
• Integrating metabolic risk factor screening with psychological interventions is recommended for comprehensive patient care.